Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

Publish Date: Dec 2020

Report Code: TBR1231A

Publisher: TBRC (Publisher)

Download Report Overview

Single User License: $4000

Explore Our Services

Already a member? Login here.

Sample Report

Report Highlights

Including: By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Covering: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.

Description:

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.
Market Characteristics – The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.
Trends And Strategies – This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.
Global Market Size And Growth – This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.
Regional Analysis – This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.
Segmentation – This section contains the market values (2023-2030) and analysis for different segments.
Regional Market Size and Growth – This section contains the region’s market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
Competitive Landscape – This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global human microbiome therapeutics market is segmented into -

By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases
By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table 1 : Global Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 2 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, %
Table 3 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, $ Million
Table 4 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, %
Table 5 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, $ Million
Table 6 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 7 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 8 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, %
Table 9 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, $ Million
Table 12 : Asia Pacific Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 13 : Asia Pacific Oncology Drugs Market, 2015-2019, $ Billion
Table 14 : Asia Pacific Gastrointestinal Market, 2015-2019, $ Billion
Table 15 : Asia Pacific Anti-infective Drugs Market, 2015-2019, $ Billion
Table 16 : Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 17 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 18 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 19 : China Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 20 : China Oncology Drugs Market, 2015-2019, $ Billion
Table 21 : China Gastrointestinal Market, 2015-2019, $ Billion
Table 22 : China Anti-infective Drugs Market, 2015-2019, $ Billion
Table 23 : China Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 24 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 25 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 26 : India Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 27 : India Oncology Drugs Market, 2015-2019, $ Billion
Table 28 : India Gastrointestinal Market, 2015-2019, $ Billion
Table 29 : India Anti-infective Drugs Market, 2015-2019, $ Billion
Table 30 : India Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 31 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 32 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 33 : Japan Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 34 : Japan Oncology Drugs Market, 2015-2019, $ Billion
Table 35 : Japan Pacific Gastrointestinal Market, 2015-2019, $ Billion
Table 36 : Japan Anti-infective Drugs Market, 2015-2019, $ Billion
Table 37 : Japan Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 38 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 39 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 40 : Australia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 41 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 42 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 43 : Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 44 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 45 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 46 : South Korea Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 47 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 48 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 49 : Western Europe Metabolic Disorders Drugs Market, 2015-2019, $ Billion
Table 50 : Western Europe Oncology Drugs Market, 2015-2019, $ Billion
Table 51 : Western Europe Gastrointestinal Market, 2015-2019, $ Billion
Table 52 : Western Europe Anti-infective Drugs Market, 2015-2019, $ Billion
Table 53 : Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 54 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 55 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 56 : UK Metabolic Disorders Drugs Market, 2015-2019, $ Billion
Table 57 : UK Oncology Drugs Market, 2015-2019, $ Billion
Table 58 : UK Gastrointestinal Market, 2015-2019, $ Billion
Table 59 : UK Anti-infective Drugs Market, 2015-2019, $ Billion
Table 60 : UK Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 61 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 62 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 63 : Germany Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 64 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 65 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 66 : France Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 67 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 68 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 69 : Eastern Europe Metabolic Drugs Market, 2015-2019, $ Billion
Table 70 : Eastern Europe Oncology Drugs Market, 2015-2019, $ Billion
Table 71 : Eastern Europe Gastrointestinal Market, 2015-2019, $ Billion
Table 72 : Eastern Europe Anti-infective Drugs Market, 2015-2019, $ Bllion
Table 73 : Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 74 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 75 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 76 : Russia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 77 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 78 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 79 : North America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 80 : North America Oncology Drugs Market, 2015-2019, $ Billion
Table 81 : North America Gastrointestinal Market, 2015-2019, $ Billion
Table 82 : North America Anti-infective Drugs Market, 2015-2019, $ Billion
Table 83 : North America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 84 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 85 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 86 : USA Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 87 : USA Oncology Drugs Market, 2015-2019, $ Billion
Table 88 : USA Gastrointestinal Market, 2015-2019, $ Billion
Table 89 : USA Anti-infective Drugs Market, 2015-2019, $ Bullion
Table 90 : USA Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 91 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 92 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 93 : South America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 94 : South America Oncology Drugs Market, 2015-2019, $ Billion
Table 95 : South America Gastrointestinal Market, 2015-2019, $ Billion
Table 96 : South America Anti-infective Drugs Market, 2015-2019, $ Billion
Table 97 : South America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 98 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 99 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 100 : Brazil Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 101 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 102 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 103 : Middle East Metabolic Disorder Drugs Market, 2015-2019, $ Billion
Table 104 : Middle East Oncology Drugs Market, 2015-2019, $ Billion
Table 105 : Middle East Gastrointestinal Market, 2015-2019, $ Billion
Table 106 : Middle East Anti-infective Drugs Market, 2015-2019, $ Billion
Table 107 : Middle East Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 108 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 109 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 110 : Africa Metabolic Disorders Drugs Market, 2015-2019, $ Billion
Table 111 : Africa Oncology Drugs Market, 2015-2019, $ Billion
Table 112 : Africa Gastrointestinal Market, 2015-2019, $ Billion
Table 113 : Africa Anti-infective Drugs Market, 2015-2019, $ Billion
Table 114 : Africa Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Table 115 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Table 116 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, $ Million
Table 117 : Global Human Microbiome Therapeutics Market, Key Competitor Estimated Ranks, 2019
Table 118 : Seres Therapeutics - Financial Performance, 2016 - 2019, $ Billion
Table 119 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), 2023 - 2030, By Country
Table 120 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Disease, 2023 - 2030
Table 121 : Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Sequencing Technology Type, 2023 - 2030
Table 122 : Human Microbiome Therapeutics Market Data Sources

Figure 1 : Global Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 2 : Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, %
Figure 3 : Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, %
Figure 4 : Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 5 : Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, %
Figure 7 : Asia-Pacific Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 8 : Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 9 : China Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 10 : China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 11 : India Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 12 : India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 13 : Japan Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 14 : Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 15 : Australia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 16 : Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 17 : Indonesia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 18 : Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 19 : South Korea Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 20 : South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 21 : Western Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 22 : Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 23 : UK Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 24 : UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 25 : Germany Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 26 : Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 27 : France Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 28 : France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 29 : Eastern Europe Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 30 : Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 31 : Russia Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 32 : Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 33 : North America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 34 : North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 35 : USA Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 36 : USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 37 : South America Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 38 : South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 39 : Brazil Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 40 : Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 41 : Middle East Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 42 : Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 43 : Africa Human Microbiome Therapeutics Market, Forecast, 2023 - 2030, $ Million
Figure 44 : Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, %
Figure 45 : Seres Therapeutics - Financial Performance, 2016 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change

Report Highlights

Related Reports

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight